Tag Archives: More

Data demonstrate efficacy of more flexible dose of regorafenib to relieve side-effects in mCRC patients

Medical oncologists administer anticancer drug regorafenib to try to improve overall survival in patients with metastatic colorectal cancer who have ceased to respond to standard therapy (known as refractory mCRC). However, some of the adverse events related to the use of this drug often limits its use in clinical practice. A study reported at the… Read More »

Pain signaling in humans more rapid than previously known

Pain signals can travel as fast as touch signals, according to a new study from researchers at Linköping University in Sweden, Liverpool John Moores University in the UK, and the National Institutes of Health (NIH) in the US. The discovery of a rapid pain-signalling system challenges our current understanding of pain. The study is published… Read More »

Why Aren’t There More Generic Drugs?

[unable to retrieve full-text content]Generic drugs are money savers. In fact the government has found that utilizing generic drugs would have translated into $ 265 billion worth of consumer savings in 2017. The question is why aren’t there more generic drugs available.First of all the manufacturer of a generic must show that’s drug is bio… Read More »

Hormone Replacement Therapy for Men: Types & More

Hormone Replacement Therapy: Definition When we talk about hormone replacement therapy (HRT) in men, we’re talking about testosterone. A small amount of testosterone is produced in the adrenal glands, but for men the majority of testosterone is produced in the testicles. Testosterone has both physical and psychological benefits.1 Physically, the hormone has several functions for… Read More »